Skip to main content
. 2024 Dec 9;11:1494882. doi: 10.3389/fcvm.2024.1494882

Figure 1.

Figure 1

The mechanisms of SGLT2 inhibitors alleviate heart failure-related Non-hypoglycemic. SGLT1, sodium-glucose cotransporter-1; AMPK, AMP-activated protein kinase; Rac2, Rac family small GTPase 2; NOS, nitric oxide synthase; BH4, tetrahydrobiopterin; ATP, adenosine triphosphate; ROS, reactive oxygen species; TNF-α, tumor necrosis factor-α; NF-κB, nuclear factor kappa-B; eNOS, endothelial nitric oxide synthase; NHE, Na+/H+ exchanger;C aMKII, calcium/calmodulin-dependent protein kinase II; SERCA2α, sarcoplasmic/endoplasmic reticulum Ca2+–ATPase 2α. Created with biorender.com.